Cafepharma Today

January 29 2025 - How might the FDA evolve under RFK Jr. and Makary?
How might the FDA evolve under RFK Jr. and Makary?
US government agencies file objection to J&J's $9B talc bankruptcy settlement
Teva Pharmaceutical posts lower revenue
Troubled 23andMe is exploring a sale of the business
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Biotechnology Drug Costs in U.S. Rise 8.7 Percent, AARP Says
Bloomberg
Thursday, September 25, 2008 - 9:01am
tags:
Glaxo Antidepressants May Damage Sperm, Impair Male Fertility
Bloomberg
Thursday, September 25, 2008 - 8:57am
tags:
Health Winners & Losers: Vertex
The Street.com
Thursday, September 25, 2008 - 8:55am
tags:
Ligand to buy Pharmacopeia for $70 million
Yahoo/AP
Thursday, September 25, 2008 - 8:55am
tags:
Discovery falls after company says new Surfaxin application won't be done until October
Yahoo/AP
Thursday, September 25, 2008 - 8:54am
tags:
Drug stocks mixed, while Sequenom soars
Marketwatch
Wednesday, September 24, 2008 - 11:28am
tags:
Medicis to restate results; suspends outlook
Reuters
Wednesday, September 24, 2008 - 11:27am
tags:
Eli Lilly to Disclose Payments to Doctors
Cafepharma Detailpiece
Wednesday, September 24, 2008 - 9:44am
tags:
Sales Force Shuffle in Full Effect
PharmExec
Wednesday, September 24, 2008 - 9:29am
tags:
Three Biotechs Hitting New 52-Week Highs
Seeking Alpha
Wednesday, September 24, 2008 - 9:25am
tags:
Forest Labs See Generic Threat
Yahoo/Zacks.com
Wednesday, September 24, 2008 - 9:22am
tags:
Sanofi Cut to `Underperform' at Credit Suisse; Novartis Raised
Bloomberg
Wednesday, September 24, 2008 - 9:22am
tags:
Bristol Vs. ImClone Heats Up As Icahn Gets Nastier
CNBC
Wednesday, September 24, 2008 - 9:15am
tags:
Pfizer Moves Into Stem Cell Research
WSJ Online
Wednesday, September 24, 2008 - 8:59am
tags:
AstraZeneca says U.S. court denies Teva motion
Marketwatch
Wednesday, September 24, 2008 - 8:58am
tags:
Teva and Kowa to create Japanese generic maker
Yahoo/AP
Wednesday, September 24, 2008 - 8:57am
tags:
Allergan's Wrinkles Need Smoothing
Yahoo/Zacks.com
Wednesday, September 24, 2008 - 7:32am
tags:
Isis Pharma Our Top Biotech
Yahoo/Zacks.com
Wednesday, September 24, 2008 - 7:10am
tags:
MannKind shares gain ground on expectations for developing inhaled insulin product
Yahoo/AP
Wednesday, September 24, 2008 - 7:09am
tags:
Lone Bristol-Myers representative on ImClone board resigns as takeover effort turns hostile
Yahoo/AP
Wednesday, September 24, 2008 - 7:09am
tags:

Pages

Latest CP Wire Articles

FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business

Latest Pharmagather Articles

Drug Channels News Roundup, January 2025: Mark Cuban Fixes Healthcare, Payers’ G2N Bubble, Pharmacists Rejoice, 340B Shenanigans, and 46Brooklyn vs. Mushrooms
Drug Channels
Bacteria (and Their Metabolites) and Depression
In the Pipeline
Some Good MASH/NASH News For Once
In the Pipeline
Attacking Estrogen-Receptor-Positive Breast Cancer
In the Pipeline
New Study Reveals Five Crucial Priorities Shaping The Future of Patient Services
Drug Channels
Killing Cancer Patients (Once the Payments Clear)
In the Pipeline
The Big Three PBMs’ 2025 Formulary Exclusions: Humira, Stelara, Private Labels, and the Shaky Future for Pharmacy Biosimilars
Drug Channels
Clinical Trial Readouts Are A-Comin'
In the Pipeline
The Current Environment
In the Pipeline

Latest Jobs

Pharmaceutical Sales Representative - Associate Territory Manager, Cardiometabolic Health
Tuscaloosa, Alabama
Eli Lilly and Company
Neuroscience Account Manager - Lancaster, PA
Lancaster, Pennsylvania, US
Lundbeck
Neuroscience Account Manager - Lancaster, PA
Lancaster, Pennsylvania, 17602
Lundbeck
Account Executive - Women's Health - W Palm Beach
Salt Lake City, Utah, 84101
Myriad Genetics
Pharmaceutical Sales Rep- Associate Territory Manager- Cardiometabolic Health
Tallahassee, Florida
Eli Lilly and Company
Psychiatry Account Manager - Atlanta East / Augusta, GA
Augusta, Georgia, US
Lundbeck
Sr. Training Manager Learning & Performance- Commercial Sales
Yardley, Pennsylvania, United States
EVERSANA
Psychiatry Account Manager - Billings, MT
Billings, Montana, US
Lundbeck
Neuroscience Account Manager - Indianapolis, IN
Indianapolis, Indiana, US
Lundbeck
Hybrid Pharmaceutical Sales Representative- EST/CST
Kansas City, Kansas, 66101
Amplity Health
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information